Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study: Efficacy and Safety of Selinexor-based Regimens for Non-Hodgkin Lymphoma

NCT05852028 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT05852028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05852028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study: Efficacy and Safety of Selinexor-based Regimens for Non-Hodgkin Lymphoma
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 15, 2022
Completion date
October 18, 2025
Enrollment
250 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dlbcl, lymphoma, t cell lymphoma